drugset / Trial / NCT00005611
BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
Phase 1
Unknown
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-188797 in treating patients who have advanced solid tumors that have not responded to previous treatment.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-188797 | Small molecule | — | Intravenous |